Acacia Research Corporation (ACTG) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings report shows strong revenue growth, especially in Intellectual Property Operations, and a significant reduction in net loss. Despite an increase in G&A expenses, the company is actively managing debt and improving EBITDA margins. The Q&A reveals cautious optimism about AMO Pharma and confidence in patent portfolio outcomes. While management's vague responses on some issues could raise concerns, the overall financial health and strategic initiatives like Bitcoin lending and oil exposure are likely to positively impact the stock price.
Key Financial Performance
Total Revenue $59.4 million, up 16% sequentially and up 155% compared to the prior year quarter. The year-over-year increase was primarily driven by the third full quarter of Deflecto.
Adjusted EBITDA $8 million for the company and $12.6 million for the Operated segment. Reasons for changes were not explicitly mentioned.
Free Cash Flow $7.7 million for the quarter. Reasons for changes were not explicitly mentioned.
GAAP Loss Per Share $0.03 per share or $0.01 per share on an adjusted basis. Reasons for changes were not explicitly mentioned.
Book Value Per Share $5.98, and $5.57 excluding noncontrolling interests, both essentially flat versus last quarter. Reasons for changes were not explicitly mentioned.
Energy Operations Revenue $14.2 million for the quarter compared to $15.8 million in the same quarter last year, reflecting a softer oil price environment year-over-year.
Manufacturing Operations Revenue $30.8 million for the quarter, representing a third consecutive sequential increase compared to $29 million in the second quarter. No comparable prior year period due to the acquisition of Deflecto in October of last year.
Industrial Operations Revenue $6.7 million for the quarter compared to $7 million in the same quarter last year. Reasons for changes were not explicitly mentioned.
Intellectual Property Operations Revenue $7.8 million for the quarter compared to $0.5 million in the same quarter last year. The increase was due to multiple settlements and licenses.
Total Consolidated G&A Expenses $16 million during the third quarter compared to $11.2 million in the same quarter of last year. The increase was primarily driven by the addition of Deflecto as part of the company's new manufacturing operations.
Energy Operations Adjusted EBITDA $6.1 million in the quarter and $21 million year-to-date. Reasons for changes were not explicitly mentioned.
Manufacturing Operations Adjusted EBITDA $2.6 million in the quarter and $6.3 million year-to-date. Reasons for changes were not explicitly mentioned.
Industrial Operations Adjusted EBITDA $0.8 million for the quarter and $2.5 million year-to-date. Reasons for changes were not explicitly mentioned.
GAAP Operating Loss $6.4 million compared to $10.3 million in the same quarter last year. This was primarily due to the inclusion of Deflecto in 2025 with no comparable operating income in 2024, along with a lower GAAP operating loss in the IP business in 2025 compared to the prior year.
GAAP Net Loss Attributable to Acacia $2.7 million or $0.03 loss per share, compared to $14 million or $0.14 loss per share in the prior year period. The decline in net loss was primarily due to the significant year-over-year increase in revenue and EBITDA, in addition to gains from the public equity portfolio and lapping the legacy legal fees from the prior year period.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Deflecto's operational initiatives: Strategic price increases, reshoring and consolidation of manufacturing operations, overhead and G&A cost reductions, and improving go-to-market motions.
Printronix's new product lines: Addition of new product lines expected to provide incremental contributions over the coming quarters.
Energy operations in the Anadarko Basin: Increased investor interest and rig counts in the Western Anadarko Basin, with focus on strategic overlap for asset acquisitions.
Deflecto's Air Distribution business: Resilient sales despite a soft construction market, supported by essential product offerings like dryer vents and air ducts.
Cost savings and operational efficiencies: Implementation of pricing strategies, cost savings initiatives, operational efficiencies, and plant consolidations to mitigate tariff pressures.
Debt reduction: Benchmark and Deflecto have paid down $24 million and $13 million in total debt, respectively, since their acquisitions.
M&A opportunities: Focus on growing the pipeline of actionable M&A opportunities with $332 million in cash, equity securities, and loans receivable available for growth.
Cherokee play development: Strategic development of undeveloped acreage in the Cherokee play, with potential monetization and capital partnerships for targeted drilling programs.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Macroeconomic and Geopolitical Headwinds: Persistent macroeconomic and geopolitical challenges are impacting the company's operations, requiring mitigation strategies such as pricing adjustments, cost savings, and operational efficiencies.
Tariff Pressures: Ongoing tariff-related challenges are affecting multiple business segments, including manufacturing and office products, leading to increased costs and delayed purchasing decisions by customers.
Class 8 Truck Market Demand: The Class 8 truck market is experiencing demand headwinds, with the weakest September orders since 2019, which is expected to persist in the near term.
Oil and Gas Price Volatility: Low oil and natural gas prices are impacting revenue in the energy segment, although hedging strategies are mitigating some of the downside risks.
Global Trade Uncertainty: Uncertainty in global trade is causing delays in purchasing decisions within the office products business, impacting revenue growth.
Soft Construction Market: The construction market is soft due to interest rate pressures, affecting sales in the air distribution business.
Debt Levels: Although debt has been reduced, the company still carries $94 million in consolidated debt, which could limit operational flexibility.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: Acacia aims to drive revenue growth across its operating businesses, focusing on organic and inorganic opportunities. The company is leveraging its strong balance sheet with $332 million in cash, equity securities, and loans receivable to pursue growth initiatives.
Energy Operations: Benchmark, the energy segment, is focusing on strategic development in the Cherokee play and considering monetization opportunities and capital partnerships for targeted drilling programs. The company is cautious about valuations for additional producing assets but sees value creation opportunities in the Anadarko Basin.
Manufacturing Segment: Deflecto is implementing operational initiatives, including price increases, reshoring, and cost reductions, to position for future growth. The Class 8 truck market is expected to rebound into 2026, supported by macroeconomic normalization and lower interest rates.
Industrial Segment: Printronix is adding new product lines to enhance revenue streams and expects incremental contributions in the coming quarters.
Intellectual Property Segment: The IP business anticipates episodic revenue fluctuations due to the timing of settlements but expects continued contributions to overall revenue.
Market Trends: The company expects macroeconomic and tariff-related headwinds to persist but is optimistic about market recovery and normalization into 2026, particularly in the Class 8 truck and construction markets.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What percent of free cash flow will be used to pay down debt in a normal environment, and what are the expected EBITDA margins?
A:The company has been using free cash flow to pay down debt to reduce leverage and interest drag, creating more flexibility for initiatives. Expected EBITDA margins are in the low to mid-teens, with improvements anticipated as operating initiatives progress across businesses.
Q:What is the update on the Cherokee properties and plans for the next year?
A:No wells have been drilled yet on the Cherokee properties. The company has been optimizing its acreage position through strategic acquisitions and swaps, creating attractive blocks for monetization.
Q:Is the $2.5 million free cash flow in Printronix's first quarter a seasonality issue?
A:Yes, it is a seasonality issue.
Q:What is the carrying value of AMO Pharma, and does its market potential indicate a positive surprise?
A:The company does not disclose the carrying value of AMO Pharma. They find it attractive and cautiously optimistic about its novel drug for myotonic dystrophy, which has garnered interest in the space. They suggest looking into similar companies like Dyne and Avidity.
Q:Does the TP Link systems issue with the U.S. government impact the value of the patent portfolio or the timing of judgment collection?
A:The geopolitical tensions do not impact the value of the patent portfolio. The judgment process is taking longer due to TP Link exercising legal rights, but the company remains confident in the outcome.
Q:Are recent private equity bankruptcies indicative of broader issues, and how does this affect acquisition strategies?
A:The bankruptcies are considered one-offs and not indicative of broader issues. The company remains cautious with leverage and is seeing better price discovery in private equity deals, though uncertainties like high interest rates persist.
Q:Was the Vantiva settlement included in the Q3 patent top line?
A:Yes, the $7.4 million settlement was included in the Q3 patent top line.
Q:Why has there been little investor relations (IR) outreach, and what are the plans to improve it?
A:The company initially held off on IR outreach to avoid premature promotion. They are now actively engaging with new investors, attending conferences, and exploring sell-side analyst coverage to raise their profile.
Q:Has the valuation of AMO Pharma changed due to recent positive advancements, and has there been interest from outside buyers?
A:The valuation has not changed despite positive advancements. The company remains cautiously optimistic but has not received interest from outside buyers.
Q:Review of Unclear Management Responses
A:Management avoided directly answering questions about the carrying value of AMO Pharma and whether there has been interest from outside buyers. They also used vague language regarding the timing of judgment collection in the TP Link case and the broader implications of private equity bankruptcies.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Class
GA expense
Instructions conference
LTM
Manufacturing
Printronix
acquisition Revolution
acreage
air
amortization expense
basin
date cash
energy date
expense GA
flow yield
headwind business
income noncash
increase addition
interest rate
manufacturing date
nature
noncash depreciation
office product
play
pressure
price environment
pricing
product line
quality
quarter
rig count
settlement
tariff
teen cash
unit
vent
ACTG Transcript
Acacia Research Corporation (ACTG) Q1 2026 Earnings Call Transcript
Unknown5-7
The earnings call revealed mixed results: record revenue in the Benchmark Energy segment, but an overall GAAP net loss and decreased revenue in other segments. The Q&A highlighted potential growth in energy operations and cost savings, but management's lack of specifics on key initiatives and stock buybacks raises uncertainty. The strategic plan shows optimism for future growth, but current financials and unclear guidance suggest a neutral short-term stock reaction.
Acacia Research Corporation (ACTG) Q4 2025 Earnings Call Transcript
Positive3-11
The earnings call reveals strong performance in several areas: a significant increase in IP revenue, improved book value per share, and strategic initiatives in energy and manufacturing segments. However, there are some uncertainties, such as the company's reluctance to provide specific guidance on certain metrics and the lack of immediate buyback announcements. Despite these, the overall sentiment is positive due to the strong financial results and optimistic guidance for future production and market opportunities.
Kinross Gold Corporation (K:CA) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call summary reveals strong production metrics, a significant increase in shareholder returns, and a 17% dividend hike, indicating financial health and commitment to shareholders. The Q&A section highlights proactive cost reduction efforts and strategic expansions. Despite some uncertainties in management responses, the overall sentiment is positive, suggesting a likely stock price increase of 2% to 8% in the next two weeks.
Acacia Research Corporation (ACTG) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings report shows strong revenue growth, especially in Intellectual Property Operations, and a significant reduction in net loss. Despite an increase in G&A expenses, the company is actively managing debt and improving EBITDA margins. The Q&A reveals cautious optimism about AMO Pharma and confidence in patent portfolio outcomes. While management's vague responses on some issues could raise concerns, the overall financial health and strategic initiatives like Bitcoin lending and oil exposure are likely to positively impact the stock price.
ACTG Slides
ACTG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
